We confirmed that JQ1 treatment of prostate cancer cells using nanomolar concentrations achieved the same overall effects as RNAi-mediated suppression of c-Myc – c-Myc mRNA and protein depletion, suppression of c-Myc function, and suppression of ligand-independent prostate cancer cell survival (Figure 6). The gene discussed is MYC; the disease is prostate carcinoma.